A system of acute stroke units is being set up in Austria, which will care for 70% of all acute strokes by 2005. This nationwide project has been planned according to evidence-based principles and contains pre-specified structural components for acute stroke care. With some exceptions in remote mountain regions, all stroke units can be reached within 90 min from any community. All units are within neurological departments. An ongoing documentation of quality performance shows that these units are being well accepted by the general population and the medical community alike.

1.
Stroke Unit Trialists’ Collaboration: Organised inpatient (stroke unit) care for stroke. The Cochrane Library, Issue 4, 2002. Oxford, Update Software Ltd.
2.
Jorgensen HS, Nakayama H, Raaschou HO, Larsen K, Hübbe P, Olsen TS: The effect of a stroke unit: Reductions in mortality, discharge rate to nursing home, length of hospital stay, and cost. A community-based study. Stroke 1995;26:1178–1182.
3.
Indredavik B, Bakke F, Slordahl SA, Rokseth R, Haheim LL: Stroke unit treatment. 10-year follow-up. Stroke 1999;30:1524–1527.
4.
Jorgensen HS, Kammersgaard LP, Nakayama H, Raaschou HO, Larsen K, Hübbe P, Olsen TS: Treatment and rehabilitation on a stroke unit improves 5-year survival. A community-based study. Stroke 1999;30:930–933.
5.
Hankey GJ, Warlow CP: Treatment and secondary prevention of stroke: Evidence, costs, and effects on individuals and populations. Lancet 1999;354:1457–1463.
6.
Brainin M, Bornstein N, Boysen G, Demarin V, et al: Acute neurological stroke care in Europe: Results of the European stroke care inventory. Eur J Neurol 2000;7:5–10.
7.
Brainin M, Kaste M, Czlonkowska A, et al: European Federation of Neurological Societies Task Force on Neurological Acute Stroke Care: The role of European neurology. Eur J Neurol 1997;4:435–441.
8.
Thomassen L, Brainin M, Demarin V, Grond M, Toni D, Venables GS: Acute stroke treatment in Europe: A questionnaire-based survey on behalf of the EFNS task force on acute neurological stroke care. Eur J Neurol, in press.
9.
Stegmayr B, Asplund K, Hulter-Asberg K, Norrving B, Peltonen M, Terent A, Wester PO, for the Riks-Stroke Collaboration: Stroke units in their natural habitat. Can results of randomized trials be reproduced in routine clinical practice? Stroke 1999;30:709–714.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.